Specifically, in vivo treatment with an anti-PD-L1 antibody prevented the development of CLL in the Eμ-TCL1 mice model, also normalizing T cells and myeloid cell populations, and restoring T-cell functions (283). The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.